Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Alzheimer's Medication Trials

Participant guide

How studies are reviewed and monitored

No study can enroll anyone until an independent committee has reviewed it, and the review continues while the study runs.

Updated

Independent review

An Institutional Review Board, or IRB, is a committee that is independent of the researchers. It reviews the study plan and the consent document before a study starts, and it keeps reviewing while the study is under way. Its job is to protect the rights and welfare of the people taking part.

Who runs Alzheimer's medication studies

As of November 17, 2026, 90 Alzheimer's medication studies are recruiting participants in the United States, according to ClinicalTrials.gov. By sponsor: industry (44), university, hospital or other (42), government (4). The sponsor is the organization responsible for a study.

See which Alzheimer's medication studies are recruiting near you.

Federal rules

Research in the United States is governed by federal regulations that set out how participants must be informed and protected. Studies of medications and devices are also overseen by the U.S. Food and Drug Administration.

Monitoring during the study

The study team follows your health at scheduled visits and records any problems you report. If a serious concern appears, a study can be changed, paused, or stopped.

Oversight lowers risk. It does not remove it. Every study has risks, and the consent document describes the ones that are known.

Talk with a study coordinator

Call (888) 927-5916 or send a short form and a coordinator will explain which studies may fit and what the next step looks like. Asking questions does not commit you to anything.

Call (888) 927-5916

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5916

or send a short form

How should we reach you?

Call